Prognosis of undetected intrapulmonary metastases in resected lung cancer

Open Access
Publisher Website
Google Scholar
Abstract
Background. Between 1975 and 1989, 839 patients with lung cancer underwent pulmonary resection at Okayama University Medical School; for this study data of the 42 (5.0%) who had intrapulmonary metastasis were analyzed. Results. The 5‐year survival rate for the 42 patients was 25.7%, which was significantly better than that of patients with Stage IV disease and extrapulmonary metastasis, none of whom survived for 3 years. The 2‐year survival rate was found to be significantly better in patients with one‐lobe metastasis (n = 37; 41.5%) than in those with two‐lobe metastasis (n = 5; 20.0%). Adenocarcinoma was the most common tumor (66.8%), followed by squamous cell carcinoma (28.6%), but the prognosis differed little between these two histologic types. Intrapulmonary metastasis did not unfavorably affect the prognosis when the primary tumor was 3 cm or less in greatest dimension and there were no lymph node metastases (T1NO). Conclusion. In patients with lung cancer and one‐lobe intrapulmonary metastasis, particularly in those with T1N0, a favorable prognosis can be expected after surgery.

This publication has 4 references indexed in Scilit: